Solventum Corporation (SOLV) PE Ratio: 9.70
Is Solventum Corporation’s P/E ratio high or low?
Solventum Corporation's P/E ratio of 9.70 is 43% below its 2-year average of 17.07, near the low end of its 2-year range (6.43–36.18).
As of Friday, June 12, 2026. 48.61% below its 12-month average of 18.87.
PE Ratio (9.70) = Close Price ($79.22) / Diluted TTM EPS ($8.17)
SOLV PE Ratio Chart
SOLV Average PE Ratio Chart
SOLV Current vs Average PE Ratio Chart
SOLV PE Ratio Metrics
PE RATIO
9.70
PE RATIO AVG TTM
18.87
PE RATIO AVG 3Y
17.07
PE RATIO AVG 5Y
17.07
PE RATIO AVG 10Y
17.07
PE RATIO AVG 15Y
17.07
PE RATIO AVG 20Y
17.07
CURRENT VS TTM AVG
-48.61%
CURRENT VS 3Y AVG
-43.18%
CURRENT VS 5Y AVG
-43.18%
CURRENT VS 10Y AVG
-43.18%
CURRENT VS 15Y AVG
-43.18%
CURRENT VS 20Y AVG
-43.18%
SOLV Competitors' PE Ratio
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Solventum Corporation (SOLV) | $13.72B | 9.70 | 18.87 | 17.07 | 17.07 |
| Align Technology, Inc. (ALGN) | $12.64B | 29.62 | 29.27 | 42.85 | 47.76 |
| Baxter International Inc. (BAX) | $10.58B | N/A | 44.53 | 34.41 | 37.43 |
| Hologic, Inc. (HOLX) | $16.97B | 31.67 | 28.12 | 30.08 | 22.83 |
| Charles River Laboratories International, Inc. (CRL) | $9.06B | N/A | 225.66 | 91.39 | 72.20 |
| Tempus AI, Inc. (TEM) | $8.65B | N/A | N/A | N/A | N/A |
| Bio-Rad Laboratories, Inc. (BIO) | $7.91B | 48.18 | 23.82 | 23.82 | 12.07 |
| Moderna, Inc. (MRNA) | $19.70B | N/A | 15.46 | 32.51 | 32.51 |
| Hims & Hers Health, Inc. (HIMS) | $6.19B | N/A | 61.96 | 88.48 | 88.48 |
| BioNTech SE (BNTX) | $22.39B | N/A | 55.73 | 22.62 | 82.47 |
P/E vs. its own history
At 9.7, P/E is in its normal range, sitting higher than 42% of its 2-year history.
2-year low
6.4
median
11.3
2-year high
36.2
P/E Comparison
Trailing P/E
9.7
Forward P/E
11.2
Forward P/E Calculation
View All Analyst EstimatesForward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$79.22
Forward EPS (Est.)
$7.06
Forward P/E
11.23
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
Solventum Corporation PE Ratio Formula & Definition
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Solventum Corporation PE Ratio FAQ
- What is the P/E ratio for Solventum Corporation (SOLV)?
- The P/E ratio for SOLV stock is 9.70.
- Is Solventum Corporation's P/E ratio high or low?
- Solventum Corporation's P/E ratio of 9.70 is 43% below its 2-year average of 17.07, near the low end of its 2-year range (6.43–36.18).
- What is the TTM average P/E ratio for Solventum Corporation (SOLV)?
- The TTM average P/E ratio for SOLV stock is 18.87.
- What is the 3Y average P/E ratio for Solventum Corporation (SOLV)?
- The 3Y average P/E ratio for SOLV stock is 17.07.
- What is the 5Y average P/E ratio for Solventum Corporation (SOLV)?
- The 5Y average P/E ratio for SOLV stock is 17.07.
- What is the 10Y average P/E ratio for Solventum Corporation (SOLV)?
- The 10Y average P/E ratio for SOLV stock is 17.07.
- What is the 15Y average P/E ratio for Solventum Corporation (SOLV)?
- The 15Y average P/E ratio for SOLV stock is 17.07.
- What is the 20Y average P/E ratio for Solventum Corporation (SOLV)?
- The 20Y average P/E ratio for SOLV stock is 17.07.
Solventum Corporation PE Ratio History
| DATE | PE RATIO |
|---|---|
| 2026-06-11 | 9.70 |
| 2026-06-10 | 9.91 |
| 2026-06-09 | 10.09 |
| 2026-06-08 | 9.64 |
| 2026-06-05 | 9.92 |
| 2026-06-04 | 10.09 |
| 2026-06-03 | 9.59 |
| 2026-06-02 | 9.35 |
| 2026-06-01 | 9.28 |
| 2026-05-29 | 9.17 |
| 2026-05-28 | 9.29 |
| 2026-05-27 | 9.29 |
| 2026-05-26 | 9.34 |
| 2026-05-22 | 9.40 |
| 2026-05-21 | 9.39 |
| 2026-05-20 | 9.32 |
| 2026-05-19 | 9.15 |
| 2026-05-18 | 9.32 |
| 2026-05-15 | 9.09 |
| 2026-05-14 | 9.11 |
| 2026-05-13 | 9.11 |
| 2026-05-12 | 9.19 |
| 2026-05-11 | 9.07 |
| 2026-05-08 | 8.98 |
| 2026-05-07 | 8.77 |
| 2026-05-06 | 8.69 |
| 2026-05-05 | 8.45 |
| 2026-05-04 | 7.59 |
| 2026-05-01 | 7.50 |
| 2026-04-30 | 7.59 |
| 2026-04-29 | 7.49 |
| 2026-04-28 | 7.60 |
| 2026-04-27 | 7.86 |
| 2026-04-24 | 7.72 |
| 2026-04-23 | 7.77 |
| 2026-04-22 | 7.78 |
| 2026-04-21 | 7.77 |
| 2026-04-20 | 7.89 |
| 2026-04-17 | 7.94 |
| 2026-04-16 | 7.76 |
| 2026-04-15 | 7.78 |
| 2026-04-14 | 7.77 |
| 2026-04-13 | 7.59 |
| 2026-04-10 | 7.41 |
| 2026-04-09 | 7.45 |
| 2026-04-08 | 7.35 |
| 2026-04-07 | 7.04 |
| 2026-04-06 | 7.12 |
| 2026-04-02 | 7.16 |
| 2026-04-01 | 7.25 |
| 2026-03-31 | 7.35 |
| 2026-03-30 | 7.15 |
| 2026-03-27 | 7.07 |
| 2026-03-26 | 7.29 |
| 2026-03-25 | 7.28 |
| 2026-03-24 | 7.21 |
| 2026-03-23 | 7.40 |
| 2026-03-20 | 7.41 |
| 2026-03-19 | 7.56 |
| 2026-03-18 | 7.56 |
| 2026-03-17 | 7.73 |
| 2026-03-16 | 7.56 |
| 2026-03-13 | 7.52 |
| 2026-03-12 | 7.45 |
| 2026-03-11 | 7.61 |
| 2026-03-10 | 7.61 |
| 2026-03-09 | 7.73 |
| 2026-03-06 | 7.82 |
| 2026-03-05 | 7.97 |
| 2026-03-04 | 7.93 |
| 2026-03-03 | 7.97 |
| 2026-03-02 | 8.22 |
| 2026-02-27 | 8.36 |
| 2026-02-26 | 8.85 |
| 2026-02-25 | 8.64 |
| 2026-02-24 | 8.45 |
| 2026-02-23 | 8.36 |
| 2026-02-20 | 8.39 |
| 2026-02-19 | 8.47 |
| 2026-02-18 | 8.62 |
| 2026-02-17 | 8.48 |
| 2026-02-13 | 8.69 |
| 2026-02-12 | 8.74 |
| 2026-02-11 | 9.38 |
| 2026-02-10 | 9.26 |
| 2026-02-09 | 8.98 |
| 2026-02-06 | 8.99 |
| 2026-02-05 | 8.86 |
| 2026-02-04 | 8.80 |
| 2026-02-03 | 8.72 |
| 2026-02-02 | 8.85 |
| 2026-01-30 | 8.86 |
| 2026-01-29 | 8.81 |
| 2026-01-28 | 8.81 |
| 2026-01-27 | 8.93 |
| 2026-01-26 | 9.09 |
| 2026-01-23 | 9.08 |
| 2026-01-22 | 9.24 |
| 2026-01-21 | 9.25 |
| 2026-01-20 | 9.09 |
| 2026-01-16 | 9.15 |
| 2026-01-15 | 9.26 |
| 2026-01-14 | 9.21 |
| 2026-01-13 | 9.21 |
| 2026-01-12 | 9.86 |
| 2026-01-09 | 9.91 |
| 2026-01-08 | 9.87 |
| 2026-01-07 | 9.69 |
| 2026-01-06 | 9.57 |
| 2026-01-05 | 9.30 |
| 2026-01-02 | 9.09 |
| 2025-12-31 | 9.12 |
| 2025-12-30 | 9.22 |
| 2025-12-29 | 9.22 |
| 2025-12-26 | 9.26 |
| 2025-12-24 | 9.23 |
| 2025-12-23 | 9.27 |
| 2025-12-22 | 9.30 |
| 2025-12-19 | 9.39 |
| 2025-12-18 | 9.28 |
| 2025-12-17 | 9.20 |
| 2025-12-16 | 9.27 |
| 2025-12-15 | 9.42 |
| 2025-12-12 | 9.55 |
| 2025-12-11 | 9.53 |
| 2025-12-10 | 9.42 |
| 2025-12-09 | 9.22 |
| 2025-12-08 | 9.51 |
| 2025-12-05 | 9.83 |
| 2025-12-04 | 9.81 |
| 2025-12-03 | 9.81 |
| 2025-12-02 | 9.85 |
| 2025-12-01 | 9.85 |
| 2025-11-28 | 9.81 |
| 2025-11-26 | 9.81 |
| 2025-11-25 | 9.87 |
| 2025-11-24 | 9.59 |
| 2025-11-21 | 9.54 |
| 2025-11-20 | 9.15 |
| 2025-11-19 | 8.90 |
| 2025-11-18 | 8.85 |
| 2025-11-17 | 8.77 |
| 2025-11-14 | 8.71 |
| 2025-11-13 | 8.66 |
| 2025-11-12 | 8.50 |
| 2025-11-11 | 8.50 |
| 2025-11-10 | 8.26 |
| 2025-11-07 | 8.23 |
| 2025-11-06 | 7.63 |
| 2025-11-05 | 31.19 |
| 2025-11-04 | 31.61 |
| 2025-11-03 | 31.39 |
| 2025-10-31 | 31.82 |
| 2025-10-30 | 31.93 |
| 2025-10-29 | 32.16 |
| 2025-10-28 | 32.68 |
| 2025-10-27 | 33.17 |
| 2025-10-24 | 32.92 |
| 2025-10-23 | 33.30 |
| 2025-10-22 | 33.53 |
| 2025-10-21 | 33.60 |
| 2025-10-20 | 33.58 |
| 2025-10-17 | 33.25 |
| 2025-10-16 | 32.92 |
| 2025-10-15 | 32.98 |
| 2025-10-14 | 32.94 |
| 2025-10-13 | 32.66 |
| 2025-10-10 | 32.50 |
| 2025-10-09 | 33.09 |
| 2025-10-08 | 33.38 |
| 2025-10-07 | 33.25 |
| 2025-10-06 | 34.00 |
| 2025-10-03 | 34.10 |
| 2025-10-02 | 34.38 |
| 2025-10-01 | 33.66 |
| 2025-09-30 | 33.64 |
| 2025-09-29 | 33.28 |
| 2025-09-26 | 32.89 |
| 2025-09-25 | 32.47 |
| 2025-09-24 | 33.10 |
| 2025-09-23 | 33.82 |
| 2025-09-22 | 33.99 |
| 2025-09-19 | 33.97 |
| 2025-09-18 | 34.27 |
| 2025-09-17 | 34.13 |
| 2025-09-16 | 34.16 |
| 2025-09-15 | 33.74 |
| 2025-09-12 | 33.82 |
| 2025-09-11 | 34.00 |
| 2025-09-10 | 32.82 |
| 2025-09-09 | 33.59 |
| 2025-09-08 | 34.38 |
| 2025-09-05 | 33.51 |
| 2025-09-04 | 33.35 |
| 2025-09-03 | 32.90 |
| 2025-09-02 | 33.10 |
| 2025-08-29 | 33.68 |
| 2025-08-28 | 33.48 |
| 2025-08-27 | 33.59 |
| 2025-08-26 | 33.60 |
| 2025-08-25 | 33.53 |
| 2025-08-22 | 33.89 |
| 2025-08-21 | 33.18 |
| 2025-08-20 | 33.57 |
| 2025-08-19 | 33.30 |
| 2025-08-18 | 32.61 |
| 2025-08-15 | 32.91 |
| 2025-08-14 | 33.73 |
| 2025-08-13 | 34.28 |
| 2025-08-12 | 33.22 |
| 2025-08-11 | 33.12 |
| 2025-08-08 | 33.82 |
| 2025-08-07 | 33.16 |
| 2025-08-06 | 33.44 |
| 2025-08-05 | 33.38 |
| 2025-08-04 | 33.74 |
| 2025-08-01 | 33.06 |
| 2025-07-31 | 32.88 |
| 2025-07-30 | 33.63 |
| 2025-07-29 | 33.89 |
| 2025-07-28 | 34.00 |
| 2025-07-25 | 34.45 |
| 2025-07-24 | 34.07 |
| 2025-07-23 | 34.29 |
| 2025-07-22 | 33.60 |
| 2025-07-21 | 33.34 |
| 2025-07-18 | 33.77 |
| 2025-07-17 | 34.04 |
| 2025-07-16 | 33.65 |
| 2025-07-15 | 33.95 |
| 2025-07-14 | 34.13 |
| 2025-07-11 | 34.01 |
| 2025-07-10 | 34.97 |
| 2025-07-09 | 34.19 |
| 2025-07-08 | 34.60 |
| 2025-07-07 | 35.13 |
| 2025-07-03 | 36.18 |
| 2025-07-02 | 36.06 |
| 2025-07-01 | 35.89 |
| 2025-06-30 | 34.95 |
| 2025-06-27 | 34.77 |
| 2025-06-26 | 34.39 |
| 2025-06-25 | 34.54 |
| 2025-06-24 | 34.55 |
| 2025-06-23 | 33.76 |
| 2025-06-20 | 33.90 |
| 2025-06-18 | 33.47 |
| 2025-06-17 | 33.53 |
| 2025-06-16 | 34.31 |
| 2025-06-13 | 34.01 |
| 2025-06-12 | 34.24 |
| 2025-06-11 | 34.29 |
| 2025-06-10 | 34.82 |
| 2025-06-09 | 34.53 |
| 2025-06-06 | 34.49 |
| 2025-06-05 | 34.73 |
| 2025-06-04 | 34.63 |
| 2025-06-03 | 34.22 |
| 2025-06-02 | 33.70 |
| 2025-05-30 | 33.68 |
Showing the most recent 260 of 555 data points. The chart above shows the full history.
Related Metrics
About Solventum Corporation
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Bryan C. Hanson